nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxyphencyclimine—CHRM3—Signaling Pathways—JUNB—coronary artery disease	0.000133	0.000133	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PLCB1—coronary artery disease	0.000133	0.000133	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PLCB1—coronary artery disease	0.000133	0.000133	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PPARGC1A—coronary artery disease	0.000133	0.000133	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—HMOX1—coronary artery disease	0.000132	0.000132	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—JUNB—coronary artery disease	0.000132	0.000132	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PLCB1—coronary artery disease	0.000132	0.000132	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—HTR7—coronary artery disease	0.00013	0.00013	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—CAT—coronary artery disease	0.00013	0.00013	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—HTR7—coronary artery disease	0.00013	0.00013	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—HTR7—coronary artery disease	0.000129	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—APOB—coronary artery disease	0.000127	0.000127	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ITGAV—coronary artery disease	0.000124	0.000124	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—KNG1—coronary artery disease	0.000124	0.000124	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ITGAV—coronary artery disease	0.000124	0.000124	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—KNG1—coronary artery disease	0.000124	0.000124	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—POMC—coronary artery disease	0.000124	0.000124	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—CREB1—coronary artery disease	0.000124	0.000124	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AGTR1—coronary artery disease	0.000123	0.000123	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—POMC—coronary artery disease	0.000123	0.000123	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—CREB1—coronary artery disease	0.000123	0.000123	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—GSTM1—coronary artery disease	0.000123	0.000123	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AGTR1—coronary artery disease	0.000123	0.000123	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ITGAV—coronary artery disease	0.000123	0.000123	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—KNG1—coronary artery disease	0.000122	0.000122	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—POMC—coronary artery disease	0.000122	0.000122	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—CREB1—coronary artery disease	0.000122	0.000122	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AGTR1—coronary artery disease	0.000122	0.000122	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—CCL2—coronary artery disease	0.000121	0.000121	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—LPL—coronary artery disease	0.000121	0.000121	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—IL6R—coronary artery disease	0.000121	0.000121	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—CCL2—coronary artery disease	0.000121	0.000121	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CXCL10—coronary artery disease	0.00012	0.00012	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—IL6R—coronary artery disease	0.00012	0.00012	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PLG—coronary artery disease	0.00012	0.00012	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CXCL10—coronary artery disease	0.00012	0.00012	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PLG—coronary artery disease	0.00012	0.00012	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—CCL2—coronary artery disease	0.000119	0.000119	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—IL6R—coronary artery disease	0.000119	0.000119	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CXCL10—coronary artery disease	0.000119	0.000119	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PLG—coronary artery disease	0.000119	0.000119	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—GPX1—coronary artery disease	0.000118	0.000118	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ADRB2—coronary artery disease	0.000117	0.000117	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ADRB2—coronary artery disease	0.000117	0.000117	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PRKCE—coronary artery disease	0.000115	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ADRB2—coronary artery disease	0.000115	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—JAK2—coronary artery disease	0.000115	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SOCS1—coronary artery disease	0.000115	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PRKCE—coronary artery disease	0.000115	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—JAK2—coronary artery disease	0.000115	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—S100B—coronary artery disease	0.000115	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—CD36—coronary artery disease	0.000115	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SOCS1—coronary artery disease	0.000115	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—S100B—coronary artery disease	0.000114	0.000114	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PRKCE—coronary artery disease	0.000114	0.000114	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—JAK2—coronary artery disease	0.000114	0.000114	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SOCS3—coronary artery disease	0.000114	0.000114	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SOCS1—coronary artery disease	0.000114	0.000114	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PPP2CA—coronary artery disease	0.000113	0.000113	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—S100B—coronary artery disease	0.000113	0.000113	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SOCS3—coronary artery disease	0.000113	0.000113	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—KITLG—coronary artery disease	0.000112	0.000112	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—TGFBR2—coronary artery disease	0.000112	0.000112	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SOCS3—coronary artery disease	0.000112	0.000112	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—KITLG—coronary artery disease	0.000112	0.000112	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—TGFBR2—coronary artery disease	0.000112	0.000112	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—KITLG—coronary artery disease	0.000111	0.000111	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—TGFBR2—coronary artery disease	0.000111	0.000111	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—STAT5A—coronary artery disease	0.00011	0.00011	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MMP3—coronary artery disease	0.00011	0.00011	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—STAT5A—coronary artery disease	0.000109	0.000109	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MMP3—coronary artery disease	0.000109	0.000109	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—MTHFR—coronary artery disease	0.000109	0.000109	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—STAT5A—coronary artery disease	0.000108	0.000108	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MMP3—coronary artery disease	0.000108	0.000108	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—APOB—coronary artery disease	0.000106	0.000106	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—APOB—coronary artery disease	0.000106	0.000106	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—CXCL8—coronary artery disease	0.000105	0.000105	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—CXCL8—coronary artery disease	0.000105	0.000105	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—APOB—coronary artery disease	0.000105	0.000105	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—JAK2—coronary artery disease	0.000105	0.000105	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—EDN1—coronary artery disease	0.000104	0.000104	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—JAK2—coronary artery disease	0.000104	0.000104	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—EDN1—coronary artery disease	0.000104	0.000104	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	0.000104	0.000104	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CCL5—coronary artery disease	0.000104	0.000104	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	0.000103	0.000103	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—AGT—coronary artery disease	0.000103	0.000103	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CCL5—coronary artery disease	0.000103	0.000103	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—EDN1—coronary artery disease	0.000103	0.000103	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CCL5—coronary artery disease	0.000102	0.000102	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—FGF1—coronary artery disease	0.000102	0.000102	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CSF2—coronary artery disease	0.000102	0.000102	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CSF2—coronary artery disease	0.000102	0.000102	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—FGF1—coronary artery disease	0.000102	0.000102	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—LPL—coronary artery disease	0.000101	0.000101	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—APOE—coronary artery disease	0.000101	0.000101	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—LPL—coronary artery disease	0.000101	0.000101	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CSF2—coronary artery disease	0.000101	0.000101	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—FGF1—coronary artery disease	0.000101	0.000101	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	0.0001	0.0001	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	0.0001	0.0001	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	0.0001	0.0001	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	0.0001	0.0001	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—APOA1—coronary artery disease	0.0001	0.0001	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—LPL—coronary artery disease	0.0001	0.0001	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	9.92e-05	9.92e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	9.92e-05	9.92e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	9.79e-05	9.79e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	9.76e-05	9.76e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	9.66e-05	9.66e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	9.56e-05	9.56e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	9.53e-05	9.53e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	9.51e-05	9.51e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	9.48e-05	9.48e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	9.44e-05	9.44e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	9.39e-05	9.39e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	9.34e-05	9.34e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	9.31e-05	9.31e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	9.22e-05	9.22e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	9.14e-05	9.14e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—C3—coronary artery disease	9.13e-05	9.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	9.11e-05	9.11e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—C3—coronary artery disease	9.1e-05	9.1e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	9.02e-05	9.02e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—C3—coronary artery disease	9.01e-05	9.01e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PPARG—coronary artery disease	8.82e-05	8.82e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	8.7e-05	8.7e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—POMC—coronary artery disease	8.7e-05	8.7e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	8.68e-05	8.68e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AGT—coronary artery disease	8.67e-05	8.67e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AGT—coronary artery disease	8.64e-05	8.64e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	8.59e-05	8.59e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AGT—coronary artery disease	8.56e-05	8.56e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—APOE—coronary artery disease	8.5e-05	8.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—LEP—coronary artery disease	8.5e-05	8.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—APOE—coronary artery disease	8.47e-05	8.47e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—LEP—coronary artery disease	8.47e-05	8.47e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—APOA1—coronary artery disease	8.4e-05	8.4e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—LEP—coronary artery disease	8.39e-05	8.39e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—APOE—coronary artery disease	8.39e-05	8.39e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—APOA1—coronary artery disease	8.37e-05	8.37e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—KDR—coronary artery disease	8.32e-05	8.32e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—KDR—coronary artery disease	8.3e-05	8.3e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—APOA1—coronary artery disease	8.29e-05	8.29e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	8.27e-05	8.27e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	8.24e-05	8.24e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—KDR—coronary artery disease	8.22e-05	8.22e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	8.16e-05	8.16e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ESR1—coronary artery disease	8.11e-05	8.11e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ESR1—coronary artery disease	8.09e-05	8.09e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—F2—coronary artery disease	8.01e-05	8.01e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—FN1—coronary artery disease	8.01e-05	8.01e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ESR1—coronary artery disease	8.01e-05	8.01e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—F2—coronary artery disease	7.99e-05	7.99e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—FN1—coronary artery disease	7.99e-05	7.99e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	7.98e-05	7.98e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	7.96e-05	7.96e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—ALB—coronary artery disease	7.93e-05	7.93e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	7.92e-05	7.92e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—F2—coronary artery disease	7.91e-05	7.91e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—FN1—coronary artery disease	7.91e-05	7.91e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	7.89e-05	7.89e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	7.88e-05	7.88e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	7.82e-05	7.82e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—KIT—coronary artery disease	7.67e-05	7.67e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—KIT—coronary artery disease	7.64e-05	7.64e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—NOS3—coronary artery disease	7.59e-05	7.59e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—KIT—coronary artery disease	7.57e-05	7.57e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	7.36e-05	7.36e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	7.33e-05	7.33e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—POMC—coronary artery disease	7.3e-05	7.3e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CREB1—coronary artery disease	7.3e-05	7.3e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—POMC—coronary artery disease	7.28e-05	7.28e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CREB1—coronary artery disease	7.28e-05	7.28e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	7.26e-05	7.26e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—POMC—coronary artery disease	7.21e-05	7.21e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CREB1—coronary artery disease	7.21e-05	7.21e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CCL2—coronary artery disease	7.14e-05	7.14e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IL6R—coronary artery disease	7.12e-05	7.12e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CCL2—coronary artery disease	7.12e-05	7.12e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IL6R—coronary artery disease	7.1e-05	7.1e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CCL2—coronary artery disease	7.05e-05	7.05e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IL6R—coronary artery disease	7.03e-05	7.03e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IGF1—coronary artery disease	7.02e-05	7.02e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IGF1—coronary artery disease	7e-05	7e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	6.99e-05	6.99e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	6.97e-05	6.97e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PTGS2—coronary artery disease	6.94e-05	6.94e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IGF1—coronary artery disease	6.93e-05	6.93e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	6.9e-05	6.9e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	6.68e-05	6.68e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	6.67e-05	6.67e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	6.66e-05	6.66e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	6.65e-05	6.65e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	6.59e-05	6.59e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	6.58e-05	6.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—FGF2—coronary artery disease	6.45e-05	6.45e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—FGF2—coronary artery disease	6.43e-05	6.43e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	6.37e-05	6.37e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—NOS3—coronary artery disease	6.37e-05	6.37e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—NOS3—coronary artery disease	6.35e-05	6.35e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	6.28e-05	6.28e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—JAK2—coronary artery disease	6.19e-05	6.19e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—JAK2—coronary artery disease	6.17e-05	6.17e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	6.11e-05	6.11e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	6.06e-05	6.06e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	6.04e-05	6.04e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	5.99e-05	5.99e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	5.65e-05	5.65e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	5.63e-05	5.63e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	5.57e-05	5.57e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	5.45e-05	5.45e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	5.44e-05	5.44e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CASP3—coronary artery disease	5.4e-05	5.4e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CASP3—coronary artery disease	5.39e-05	5.39e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	5.38e-05	5.38e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—IL6—coronary artery disease	5.37e-05	5.37e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—IL6—coronary artery disease	5.35e-05	5.35e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	5.33e-05	5.33e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	5.3e-05	5.3e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CCND1—coronary artery disease	5.26e-05	5.26e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CCND1—coronary artery disease	5.24e-05	5.24e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	5.19e-05	5.19e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MMP9—coronary artery disease	5.11e-05	5.11e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MMP9—coronary artery disease	5.09e-05	5.09e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	5.04e-05	5.04e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	4.95e-05	4.95e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	4.94e-05	4.94e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	4.89e-05	4.89e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	4.59e-05	4.59e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	4.57e-05	4.57e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	4.53e-05	4.53e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PIK3CA—coronary artery disease	4.27e-05	4.27e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	4.21e-05	4.21e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	4.2e-05	4.2e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	4.16e-05	4.16e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	4.13e-05	4.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	4.11e-05	4.11e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	4.07e-05	4.07e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	3.58e-05	3.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	3.57e-05	3.57e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	3.54e-05	3.54e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—AKT1—coronary artery disease	3.49e-05	3.49e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IL6—coronary artery disease	3.17e-05	3.17e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IL6—coronary artery disease	3.16e-05	3.16e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IL6—coronary artery disease	3.13e-05	3.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AKT1—coronary artery disease	2.93e-05	2.93e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AKT1—coronary artery disease	2.92e-05	2.92e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	2.89e-05	2.89e-05	CbGpPWpGaD
